Status:
COMPLETED
Allogeneic Stem Cell Transplantation (ALLO-SCT) in Elderly: 17-years Retrospective GITMO Survey
Lead Sponsor:
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Conditions:
Allogeneic Stem Cell Transplantation in Elderly Patients
Eligibility:
All Genders
60+ years
Brief Summary
The age of patients' population is increasing every year, as the life expectancy. Thus, the incidence and prevalence of hematological cancers is increasing. In particular, acute leukemias and myelodis...
Eligibility Criteria
Inclusion
- This study will enrol patients older than 60 years who received hematopoietic stem cell transplantation (HSCT) between 1st January 2000 and 31st December 2017.
Exclusion
Key Trial Info
Start Date :
February 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
2061 Patients enrolled
Trial Details
Trial ID
NCT04469985
Start Date
February 1 2020
End Date
December 31 2020
Last Update
July 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chair of Hematology and Bone marrow Transplant Unit
Brescia, Italy, 25123